$CSL
CARLISLE COMPANIES INC

2024 Q2 Form 10-Q Financial Statement

#000079005124000085 Filed on April 26, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $1.451B $1.097B
YoY Change -4.93% -6.98%
Cost Of Revenue $881.7M $697.6M
YoY Change -11.35% -16.16%
Gross Profit $568.9M $398.9M
YoY Change 7.08% 15.06%
Gross Profit Margin 39.22% 36.38%
Selling, General & Admin $189.3M $166.8M
YoY Change -0.05% -11.56%
% of Gross Profit 33.27% 41.81%
Research & Development $9.300M $9.200M
YoY Change -29.01% -40.65%
% of Gross Profit 1.63% 2.31%
Depreciation & Amortization $43.10M $16.60M
YoY Change -26.32% -28.76%
% of Gross Profit 7.58% 4.16%
Operating Expenses $198.6M $176.0M
YoY Change -1.93% -13.77%
Operating Profit $377.5M $225.2M
YoY Change 14.81% 59.72%
Interest Expense -$5.000M -$10.70M
YoY Change -65.03% -156.91%
% of Operating Profit -1.32% -4.75%
Other Income/Expense, Net $100.0K $300.0K
YoY Change -150.0% -75.0%
Pretax Income $372.6M $214.8M
YoY Change 19.0% 67.81%
Income Tax $87.40M $43.90M
% Of Pretax Income 23.46% 20.44%
Net Earnings $712.4M $192.3M
YoY Change 266.08% 89.09%
Net Earnings / Revenue 49.11% 17.54%
Basic Earnings Per Share $15.03 $4.02
Diluted Earnings Per Share $14.84 $3.97
COMMON SHARES
Basic Shares Outstanding 47.60M shares 47.75M shares
Diluted Shares Outstanding 47.90M shares 48.40M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.736B $552.6M
YoY Change 357.76% 30.36%
Cash & Equivalents $1.736B $552.6M
Short-Term Investments
Other Short-Term Assets $64.10M $67.50M
YoY Change -90.49% -32.97%
Inventory $426.3M $399.8M
Prepaid Expenses $21.80M $19.10M
Receivables $903.6M $700.8M
Other Receivables $0.00 $0.00
Total Short-Term Assets $3.152B $3.463B
YoY Change 17.05% 60.92%
LONG-TERM ASSETS
Property, Plant & Equipment $664.2M $653.7M
YoY Change -16.85% -22.22%
Goodwill $1.337B $1.199B
YoY Change -33.74% -45.58%
Intangibles $1.450B $1.227B
YoY Change -6.58% -31.93%
Long-Term Investments
YoY Change
Other Assets $124.8M $102.7M
YoY Change 9.19% -12.15%
Total Long-Term Assets $3.576B $3.183B
YoY Change -20.23% -35.88%
TOTAL ASSETS
Total Short-Term Assets $3.152B $3.463B
Total Long-Term Assets $3.576B $3.183B
Total Assets $6.728B $6.646B
YoY Change -6.24% -6.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $363.4M $322.9M
YoY Change -8.51% -12.02%
Accrued Expenses $296.3M $218.7M
YoY Change 21.38% -1.93%
Deferred Revenue $27.10M $26.80M
YoY Change 0.37% -29.47%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $402.9M $402.8M
YoY Change 33.41% 33.38%
Total Short-Term Liabilities $1.090B $1.175B
YoY Change 4.25% 26.31%
LONG-TERM LIABILITIES
Long-Term Debt $1.887B $1.887B
YoY Change -17.31% -17.31%
Other Long-Term Liabilities $439.0M $422.5M
YoY Change -46.25% -25.79%
Total Long-Term Liabilities $2.634B $2.612B
YoY Change -14.99% -16.48%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.090B $1.175B
Total Long-Term Liabilities $2.634B $2.612B
Total Liabilities $3.724B $3.787B
YoY Change -10.14% -6.67%
SHAREHOLDERS EQUITY
Retained Earnings $6.457B $5.785B
YoY Change 23.08% 13.65%
Common Stock $649.0M $641.5M
YoY Change 6.34% 7.87%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.004B $2.859B
YoY Change
Total Liabilities & Shareholders Equity $6.728B $6.646B
YoY Change -6.24% -6.6%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $712.4M $192.3M
YoY Change 266.08% 89.09%
Depreciation, Depletion And Amortization $43.10M $16.60M
YoY Change -26.32% -28.76%
Cash From Operating Activities $183.4M $163.5M
YoY Change -17.05% 9.29%
INVESTING ACTIVITIES
Capital Expenditures $24.90M $32.50M
YoY Change -16.72% -19.15%
Acquisitions
YoY Change
Other Investing Activities $1.584B -$300.0K
YoY Change 27680.7% -96.25%
Cash From Investing Activities $1.559B -$32.00M
YoY Change -6540.5% 0.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -575.8M -$166.1M
YoY Change 147.87% 75.21%
NET CHANGE
Cash From Operating Activities 183.4M $163.5M
Cash From Investing Activities 1.559B -$32.00M
Cash From Financing Activities -575.8M -$166.1M
Net Change In Cash 1.166B -$35.30M
YoY Change -3394.35% -247.7%
FREE CASH FLOW
Cash From Operating Activities $183.4M $163.5M
Capital Expenditures $24.90M $32.50M
Free Cash Flow $158.5M $131.0M
YoY Change -17.1% 19.74%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P9M
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
697600000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
621400000 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
166800000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
142200000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9200000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6800000 usd
CY2024Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
2300000 usd
CY2023Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1500000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
225200000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
120700000 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-18600000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-18800000 usd
CY2024Q1 us-gaap Interest Income Other
InterestIncomeOther
7900000 usd
CY2023Q1 us-gaap Interest Income Other
InterestIncomeOther
4500000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
300000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000000.0 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
214800000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
107400000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
43900000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23800000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
170900000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
83600000 usd
CY2024Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
21900000 usd
CY2023Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
21200000 usd
CY2024Q1 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
500000 usd
CY2023Q1 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
3100000 usd
CY2024Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
21400000 usd
CY2023Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
18100000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
192300000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
101700000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
3.57
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.63
CY2024Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0.45
CY2023Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0.36
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.02
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.99
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
3.52
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.61
CY2024Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
0.45
CY2023Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
0.35
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.97
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.96
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47800000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51100000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48400000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51700000 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
192300000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
101700000 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-9700000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
13000000.0 usd
CY2024Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-500000 usd
CY2023Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-300000 usd
CY2024Q1 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
1000000.0 usd
CY2023Q1 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
1900000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-8200000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
15200000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
184100000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
116900000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
552600000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
576700000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4800000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3900000 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
700800000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
615300000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
399800000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
361700000 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
19100000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
21200000 usd
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
67500000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
107600000 usd
CY2024Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
1723600000 usd
CY2023Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
1725600000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
3463400000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
3408100000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
653700000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
655200000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
1199300000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
1202500000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1226800000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1252900000 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
102700000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
101300000 usd
CY2024Q1 us-gaap Assets
Assets
6645900000 usd
CY2023Q4 us-gaap Assets
Assets
6620000000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
322900000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
245500000 usd
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
402800000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
402700000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
218700000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
292900000 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
26800000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
26400000 usd
CY2024Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
203500000 usd
CY2023Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
218800000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1174700000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1186300000 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1886900000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1886700000 usd
CY2024Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
302500000 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
297600000 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
422500000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
420400000 usd
CY2024Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2611900000 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2604700000 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q1 csl Preferred Stock Shares Unissued
PreferredStockSharesUnissued
5000000 shares
CY2023Q4 csl Preferred Stock Shares Unissued
PreferredStockSharesUnissued
5000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47600000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47700000 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
78700000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
78700000 usd
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
562800000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
553800000 usd
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
31000000 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
30900000 shares
CY2024Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
3447700000 usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
3326400000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-119300000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-111100000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5784800000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5634000000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
2859300000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2829000000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6645900000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6620000000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
192300000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
101700000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
16600000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
23300000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
22300000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
37200000 usd
CY2024Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
5600000 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
6900000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
12000000.0 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
11400000 usd
CY2024Q1 csl Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
-100000 usd
CY2023Q1 csl Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
1500000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-3700000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-2300000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
87200000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-100200000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
52800000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
28900000 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-9200000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-3500000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2100000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-20200000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
78400000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-300000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-40700000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-126100000 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
4500000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
3200000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-2400000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-6500000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
163500000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
149600000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
32500000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
40200000 usd
CY2024Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
200000 usd
CY2023Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
500000 usd
CY2024Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-300000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-8000000.0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-32000000.0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-31700000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
150000000.0 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
50000000.0 usd
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
41500000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
38900000 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
42500000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4800000 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
16200000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
9900000 usd
CY2024Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-900000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-800000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-166100000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-94800000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-700000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
800000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-35300000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
23900000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
-11200000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
2500000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
576700000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
364700000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
552600000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
386100000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3024400000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
101700000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
15200000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.75
CY2023Q1 us-gaap Dividends Cash
DividendsCash
39000000.0 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
50200000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
6200000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
3058300000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2829000000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
192300000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-8200000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.85
CY2024Q1 us-gaap Dividends Cash
DividendsCash
41500000 usd
CY2024Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
150500000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
38200000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
2859300000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.63
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
3.52
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.61
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47800000 shares
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2024Q1 us-gaap Revenues
Revenues
1096500000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
225200000 usd
CY2023Q1 us-gaap Revenues
Revenues
892600000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
120700000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
170900000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
83600000 usd
CY2024Q1 us-gaap Dividends
Dividends
41500000 usd
CY2023Q1 us-gaap Dividends
Dividends
39000000.0 usd
CY2024Q1 us-gaap Undistributed Earnings
UndistributedEarnings
129400000 usd
CY2023Q1 us-gaap Undistributed Earnings
UndistributedEarnings
44600000 usd
CY2024Q1 csl Percentage Of Undistributed Earnings Allocated To Common Shareholders
PercentageOfUndistributedEarningsAllocatedToCommonShareholders
0.998
CY2023Q1 csl Percentage Of Undistributed Earnings Allocated To Common Shareholders
PercentageOfUndistributedEarningsAllocatedToCommonShareholders
0.998
CY2024Q1 us-gaap Undistributed Earnings Loss Available To Common Shareholders Basic
UndistributedEarningsLossAvailableToCommonShareholdersBasic
129100000 usd
CY2023Q1 us-gaap Undistributed Earnings Loss Available To Common Shareholders Basic
UndistributedEarningsLossAvailableToCommonShareholdersBasic
44500000 usd
CY2024Q1 us-gaap Dividends Common Stock
DividendsCommonStock
41400000 usd
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
38900000 usd
CY2024Q1 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
170500000 usd
CY2023Q1 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
83400000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47800000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51100000 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
200000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
200000 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
400000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
400000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48400000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51700000 shares
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
3.57
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51100000 shares
CY2024Q1 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
47900000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
51200000 shares
CY2024Q1 csl Percentage Of Undistributed Earnings Allocated To Common Shareholders
PercentageOfUndistributedEarningsAllocatedToCommonShareholders
0.998
CY2023Q1 csl Percentage Of Undistributed Earnings Allocated To Common Shareholders
PercentageOfUndistributedEarningsAllocatedToCommonShareholders
0.998
CY2024Q1 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted
21400000 usd
CY2024Q1 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
21400000 usd
CY2023Q1 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
18100000 usd
CY2023Q1 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted
18100000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
191900000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
191900000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
101500000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
101500000 usd
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
700000 shares
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
20600000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
26600000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
25600000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
24500000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
23500000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
22500000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
186000000.0 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
324000000.0 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
294800000 usd
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
6900000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
6500000 usd
CY2024Q1 csl Contract With Customer Liability Revenue Deferred In Period
ContractWithCustomerLiabilityRevenueDeferredInPeriod
12200000 usd
CY2023Q1 csl Contract With Customer Liability Revenue Deferred In Period
ContractWithCustomerLiabilityRevenueDeferredInPeriod
12300000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
329300000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
300600000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1096500000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
892600000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1096500000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
892600000 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9700000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9000000.0 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
900000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1200000 usd
CY2024Q1 csl Share Based Payment Arrangement Amortization Of Capitalized Cost
ShareBasedPaymentArrangementAmortizationOfCapitalizedCost
1000000.0 usd
CY2023Q1 csl Share Based Payment Arrangement Amortization Of Capitalized Cost
ShareBasedPaymentArrangementAmortizationOfCapitalizedCost
1300000 usd
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
9800000 usd
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
9100000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.204
CY2024Q1 csl Expected Effective Income Tax Rate Continuing Operations
ExpectedEffectiveIncomeTaxRateContinuingOperations
0.237
CY2024Q1 csl Discrete Income Tax Expense Benefit
DiscreteIncomeTaxExpenseBenefit
-7100000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.222
CY2024Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
128400000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
120900000 usd
CY2024Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
28400000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
26200000 usd
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
251600000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
222500000 usd
CY2024Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
8600000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
7900000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
399800000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
361700000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
56200000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
77200000 usd
CY2024Q1 csl Accrued Customer Incentives Current
AccruedCustomerIncentivesCurrent
52500000 usd
CY2023Q4 csl Accrued Customer Incentives Current
AccruedCustomerIncentivesCurrent
112700000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
25900000 usd
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
24900000 usd
CY2024Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
20400000 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
19900000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
63700000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
58200000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
218700000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
292900000 usd
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
24900000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
25200000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
5300000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
3300000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
4200000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
3300000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardProductWarrantyAccrualForeignCurrencyTranslationGainLoss
100000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardProductWarrantyAccrualForeignCurrencyTranslationGainLoss
-100000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
25900000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
25300000 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
10300000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
10600000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
2289700000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
2289400000 usd
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
402800000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
402700000 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1886900000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1886700000 usd
CY2024Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
17600000 usd
CY2023Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
17600000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
19900000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
19800000 usd
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000790051-24-000085-index-headers.html Edgar Link pending
0000790051-24-000085-index.html Edgar Link pending
0000790051-24-000085.txt Edgar Link pending
0000790051-24-000085-xbrl.zip Edgar Link pending
csl-20240331.htm Edgar Link pending
csl-20240331.xsd Edgar Link pending
csl-20240331_g1.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
q12024-exhibit311form10xq.htm Edgar Link pending
q12024-exhibit312form10xq.htm Edgar Link pending
q12024-exhibit321form10xq.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
csl-20240331_cal.xml Edgar Link unprocessable
csl-20240331_def.xml Edgar Link unprocessable
csl-20240331_lab.xml Edgar Link unprocessable
csl-20240331_htm.xml Edgar Link completed
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
csl-20240331_pre.xml Edgar Link unprocessable